Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients-Reference-Cited by-同舟云学术

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Published:2019-08 Issue:2 Volume:71 Page:265-273
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Cabibbo Giuseppe^ORCID,Celsa Ciro^ORCID,Calvaruso Vincenza^ORCID,Petta Salvatore^ORCID,Cacciola Irene^ORCID,Cannavò Maria Rita,Madonia Salvatore,Rossi Margherita,Magro Bianca,Rini Francesca,Distefano Marco,Larocca Licia,Prestileo Tullio,Malizia Giuseppe,Bertino Gaetano,Benanti Francesco,Licata Anna,Scalisi Ignazio,Mazzola Giovanni,Di Rosolini Maria Antonietta,Alaimo Giuseppe,Averna Alfonso,Cartabellotta Fabio,Alessi Nicola,Guastella Salvatore,Russello Maurizio,Scifo Gaetano,Squadrito Giovanni,Raimondo Giovanni,Trevisani Franco^ORCID,Craxì Antonio,Di Marco Vito,Cammà Calogero

Funder

Gilead

Abbvie

Publisher

Elsevier BV

Subject

Hepatology

Reference40 articles.

1. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

2. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma;J Hepatol,2018

3. Hepatic decompensation is the major driver of death in HCV infected cirrhotic patients with successfully treated early hepatocellular carcinoma;Cabibbo;J Hepatol,2017

4. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma;Cabibbo;Liver Int,2017

5. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial;Bruix;Lancet Oncol,2015

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02

2. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

3. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01

4. Merits and boundaries of the Barcelona Clinic Liver Cancer Staging and Treatment Algorithm: learning from the past to improve the future with a novel proposal.;Journal of Hepatology;2024-01

5. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment;Journal of the Formosan Medical Association;2024-01